[1] Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis:a comprehensive review[J]. Clin Rev Allergy Immunol,2016, 50(3):377-389. [2] Wang Y, Wang L L, Yang H Y, et al. Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells[J]. Am J Transl Res,2016, 8(7):3188-3196. [3] Wang Y, Mi Y, Li D, et al. Acute leukemia association with psoriasis:a report on 100 patients from a single center in China[J]. Am J Hematol, 2010, 85(5):378-379. [4] Wong T, Hsu L, Liao W. Phototherapy in psoriasis:a review of mechanisms of action[J]. J Cutan Med Surg, 2013, 17(1):6-12. [5] Carracedo A, Weiss D, Leliaert A K, et al. A metabolic prosurvival role for PML in breast cancer[J]. J Clin Invest, 2012, 122(9):3088-3100. [6] Rokudai S, Laptenko O, Arnal S M, et al. MOZ increases p53 acetylation and premature senescence through its complex formation with PML[J]. Proc Natl Acad Sci U S A, 2013, 110(10):3895-3900. [7] Hoetelmans R W. Nuclear partners of Bcl-2:Bax and PML[J]. DNA Cell Biol, 2004, 23(6):351-354. [8] Salomoni P, Dvorkina M, Michod D. Role of the promyelocytic leukaemia protein in cell death regulation[J]. Cell Death Dis, 2012, 3:e247. [9] Yeung P L, Denissova N G, Nasello C,et al. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination[J]. J Cell Biochem, 2012, 113(5):1787-1799. [10] Yen C C, Tsao Y P, Chen P C, et al. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery[J]. J Surg Oncol, 2011, 103(8):761-767. [11] Yazici A C, Karabulut A A, Ozen O,et al. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis:a quantitative comparative study[J]. J Dermatol, 2007, 34(6):367-374. [12] Ivanschitz L, Takahashi Y, Jollivet F,et al. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence[J]. Proc Natl Acad Sci U S A, 2015, 112(46):14278-14283. [13] Pinton P, Giorgi C, Pandolfi P P. The role of PML in the control of apoptotic cell fate:a new key player at ER-mitochondria sites[J]. Cell Death Differ, 2011, 18(9):1450-1456. [14] Haupt S, Mitchell C, Corneille V, et al. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner[J]. Cell Cycle, 2013, 12(11):1722-1731. [15] Batinac T, Zamolo G, Hadzisejdić I, et al. Expression of Bcl-2 family proteins in psoriasis[J]. Croat Med J, 2007, 48(3):319-326. [16] Myś Liwiec H, Flisiak I, Baran A,et al. Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients[J]. Folia Histochem Cytobiol, 2012, 50(1):75-79. [17] 张晓岚, 陈洋,姜奕.进展期寻常型银屑病病人皮损中IL-22的表达[J].中国医科大学学报,2015,44(4):362-364. [18] 史雅琼,马建伟,庞晓文,等.银屑病合并代谢综合征病人血hs-CRP、IL-6水平及理化指标变化的意义[J].解放军医药杂志,2015,27(9):21-23. |